Revisiting the specificity of the MHC class II transactivator CIITA in vivo

European Journal of Immunology

Volumn 36, Issue 6, 2006, Pages 1548-1558

  Otten, Luc A ^a,b   LeibundGut Landmann, Salomé ^a,d   Huarte, Joachim ^a   Kos Braun, Isabelle C ^a,e   Lavanchy, Christine ^b   Barras, Emmanuèle ^a   Borisch, Bettina ^a   Steimle, Viktor ^c   Acha Orbea, Hans ^b   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CIITA; Gene expression; MHC class II; Th cell differentiation; Transgenic mice

Indexed keywords

CATHEPSIN E; COLLAGEN TYPE 1; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 4; KARYOPHERIN ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLEXIN; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR; TRANSACTIVATOR CIITA PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TYROSINE TRANSFER RNA LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC CODE; IN VIVO STUDY; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE; TRANSGENICS; UPREGULATION;

ANIMALS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, TRANSGENIC; NUCLEAR PROTEINS; RNA, MESSENGER; SUBSTRATE SPECIFICITY; TH1 CELLS; TH2 CELLS; TRANS-ACTIVATORS;

EID: 33745427550     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535687     Document Type: Article

References (30)

1. Steimle, V., Otten, L. A., Zufferey, M. and Mach, B., Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993. 75: 135-146.
2. Reith, W. and Mach, B., The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 2001. 19: 331-373.
3. Ting, J. P. and Trowsdale, J., Genetic control of MHC class II expression. Cell 2002. 109 Suppl: S21-S33.
4. LeibundGut-Landmann, S., Waldburger, J. M., Krawczyk, M., Otten, L. A., Suter, T., Fontana, A., Acha-Orbea, H. and Reith, W., Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 2004. 34: 1513-1525.
5. Reith, W., LeibundGut-Landmann, S. and Waldburger, J. M., Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 2005. 5: 793-806.
6. Gobin, S. J., Peijnenburg, A., Keijsers, V. and van den Elsen, P. J., Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997. 6: 601-611.
7. Martin, B. K., Chin, K. C., Olsen, J. C., Skinner, C. A., Dey, A., Ozato, K. and Ting, J. P., Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 1997. 6: 591-600.
8. Gourley, T., Roys, S., Lukacs, N. W., Kunkel, S. L., Flavell, R. A. and Chang, C. H., A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 1999. 10: 377-386.
9. Gourley, T. S. and Chang, C. H., Cutting edge: The class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression. J. Immunol. 2001. 166: 2917-2921.
10. Yee, C. S., Van, Y., Li P., Klemsz, M. J., Blum, J. S. and Chang, C. H., Cathepsin E: A novel target for regulation by class II transactivator. J. Immunol. 2004. 172: 5528-5534.
11. Yee, C. S., Yao, Y., Xu, Q., McCarthy, B., Sun-Lin, D., Tone, M., Waldmann, H. and Chang, C. H., Enhanced production of IL-10 by dendritic cells deficient in CIITA. J. Immunol. 2005. 174: 1222-1229.
12. Zhu, X. S. and Ting, J. P., A 36-amino-acid region of CIITA is an effective inhibitor of CBP: Novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters. Mol. Cell. Biol. 2001. 21: 7078-7088.
13. Nagarajan, U. M., Bushey, A. and Boss, J. M., Modulation of gene expression by the MHC class II transactivator. J. Immunol. 2002. 169: 5078-5088.
14. Wong, A. W., Brickey, W. J., Taxman, D. J., van Deventer, H. W., Reed, W., Gao, J. X, Zheng, P. et al., CIITA-regulated Plexin-A1 affects T-cell-dendritic cell interactions. Nat. Immunol. 2003. 4: 891-898.
15. + T lymphocytes. J. Immunol. 2003. 170: 1150-1157.
16. Park W. S., Bae, Y., Chung, D. H., Choi, Y. L., Kim, B. K., Sung, Y. C., Choi, E. Y. et al., T cell expression of CIITA represses Th1 immunity. Int. Immunol. 2004. 16: 1355-1364.
17. Baton, F., Deruyffelaere, C., Chapin, M., Prod'homme, T., Charron, D., Al-Daccak, R. and Alcaide-Loridan, C., Class II transactivator (CIITA) isoform expression and activity in melanoma. Melanoma Res. 2004. 14: 453-461.
18. Patel, D. R., Li, W., Park J. S., Sofi, M. H., Gourley, T. S., Hangoc, G., Kaplan, M. H. and Chang, C. H., Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus. Cell. Immunol. 2005. 233: 30-40.
19. LeibundGut-Landmann, S., Waldburger, J. M., Reis e Sousa, C., Acha-Orbea, H. and Reith, W., MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 2004. 5: 899-908.
20. Gourley, T. S., Patel, D. R., Nickerson, K., Hong, S. C. and Chang, C. H., Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator. J. Immunol. 2002. 168: 4414-4419.
21. Sisk, T. J., Gourley, T., Roys, S. and Chang, C. H., MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J. Immunol. 2000. 165: 2511-2517.
22. Chang, C. H., Gourley, T. and Patel, D., CIITA expression and Th1-Th2 balance. J. Immunol. 2003. 170: 4425; author reply 4425.
23. Patel, D. R., Kaplan, M. H. and Chang, C. H., Altered Th1 cell differentiation programming by CIITA deficiency. J. Immunol. 2004. 173: 5501-5508.
24. Ho, I. C. and Glimcher, L. H., Transcription: Tantalizing times for T cells. Cell 2002. 109 Suppl: S109-S120.
25. Chang, C. H., Guerder, S., Hong, S. C., van Ewijt, W. and Flavell, R. A., Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996. 4: 167-178.
26. Itoh-Lindstrom, Y., Piskurich, J. F., Felix, N. J., Wang, Y., Brickey, W. J., Platt, J. L, Koller, B. H. and Ting, J. P., Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 1999. 163: 2425-2431.
27. Williams, G. S., Malin, M., Vremec, D., Chang, C. H., Boyd, R., Benoist, C. and Mathis, D., Mice lacking the transcription factor CIITA - a second look. Int. Immunol. 1998. 10: 1957-1967.
28. Muhlethaler-Mottet, A., Otten, L. A., Steimle, V. and Mach, B., Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 1997. 16: 2851-2860.
29. Kontgen, F., Suss, G., Stewart, C., Steinmetz, M. and Bluethmann, H., Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 1993. 5: 957-964.
30. Otten, L. A., Steimle, V., Bontron, S. and Mach, B., Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 1998. 28: 473-478.